Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
Tan G, Kasuya H, Sahin TT, Yamamura K, Wu Z, Koide Y, Hotta Y, Shikano T, Yamada S, Kanzaki A, Fujii T, Sugimoto H, Nomoto S, Nishikawa Y, Tanaka M, Tsurumaru N, Kuwahara T, Fukuda S, Ichinose T, Kikumori T, Takeda S, Nakao A, Kodera Y.
Tan G, et al. Among authors: kodera y.
Int J Cancer. 2015 Apr 1;136(7):1718-30. doi: 10.1002/ijc.29163. Epub 2014 Sep 27.
Int J Cancer. 2015.
PMID: 25156870